Name: Puma Biotechnology, Inc. (PBYI) Financial Statements
Creator: FinSpry

Puma Biotechnology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Puma Biotechnology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	230.47	235.64	228.03	253.16	225.11	272.26	250.99
Cost of Revenue	64.40	62.68	55.09	63.70	39.37	0.00	34.62
Gross Profit	166.06	172.96	172.94	189.45	185.74	272.26	216.37
Operating Expenses
Research & Development	54.94	50.38	52.24	71.87	97.65	132.85	164.85
Selling, General & Administrative	80.16	89.93	89.98	116.29	118.49	141.64	146.17
Operating Expenses	135.10	140.32	142.22	188.16	216.14	311.31	311.03
Operating Income	30.97	32.64	30.72	1.29	-30.40	-39.05	-94.66
Other Income/Expense
Interest Income	4.72	2.61	0.81	0.16	0.49	0.00	1.80
Interest Expense	-12.45	-13.33	11.59	-12.81	-14.05	0.00	10.99
Other Income/Expense	0.86	-0.76	-19.48	0.29	15.83	24.33	-9.71
Income
Income Before Tax	24.10	22.67	0.46	-28.80	-59.79	-75.54	-113.56
Income Tax Expense	-6.18	1.08	0.46	0.32	0.21	0.05	0.02
Net Income	30.28	21.59	0.00	-29.13	-60.00	-75.60	-113.58
Net Income - Continuous Operations	30.28	21.59	0.00	-29.13	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	42.49	34.19	21.89	12.60	-35.71	-52.45	-95.19
EBIT	30.97	22.67	12.05	1.29	-45.74	-60.52	-102.57
Depreciation & Amortization	11.52	0.40	9.84	11.31	0.90	0.90	0.00
Earnings Per Share
Basic EPS	1.00	-	-	-1.00	-2.00	-2.00	-3.00
Diluted EPS	1.00	-	-	-1.00	-2.00	-2.00	-3.00
Basic Shares Outstanding	48.65	47.13	44.67	40.64	39.58	38.77	37.94
Diluted Shares Outstanding	49.10	47.55	44.93	40.64	39.58	38.77	37.94